Uncategorised - European Medical Journal

Extracellular Volume Fraction Predicts Cirrhosis Severity Accurately

This new study highlights the growing role of extracellular volume measurement using spectral CT, which quantifies the proportion of extracellular matrix.

H. pylori Infection Worsens Gastric Cancer Prognosis

A study has found that H. pylori infection in gastric cancer is linked to reduced tumour-infiltrating lymphocytes and poorer patient outcomes.

Preeclampsia During Term Births Linked to Long-Term Kidney Risk in Offspring

Offspring of mothers who experienced preeclampsia during term pregnancies face higher long-term risks of kidney disease, according to a nationwide Danish study.

Immunotherapy After Surgery May Reduce HNSCC Recurrence: ASCO 2025

Adding nivolumab to postoperative chemoradiotherapy may reduce the likelihood of recurrence in patients with resected, high-risk head and neck squamous cell carcinoma (HNSCC), according to results from the Phase III NIVOPOSTOP trial presented at the 2025 ASCO Annual Meeting.

PD-L1-Positive TNBC Sees Slower Disease Growth: ASCO 2025

Patients with unresectable, locally advanced or metastatic PD-L1-positive triple-negative breast cancer (TNBC) experienced longer progression-free survival when treated with sacituzumab govitecan and pembrolizumab, compared to the current standard of chemotherapy plus pembrolizumab, according to new findings presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.

Loneliness is Linked to Higher Heart Disease Risk Across Cultures

Loneliness increases heart disease risk by 15% in both US and South Korea, major study finds.

Timely Statin Use Critical for Reducing Heart Attack and Stroke in Diabetes

Delaying statins raises cardiovascular risk in diabetes; timely treatment is essential to improve patient outcomes.

Psoriasis and Hidden Inflammation: A Cardiovascular Risk Uncovered

In this study, researchers examined three international cohorts of patients with moderate-to-severe psoriasis undergoing biologic therapy.

β-Lactams Outperform Vancomycin in MSSA Treatment

IN a new meta-analysis, β-lactam antibiotics demonstrated significantly faster clinical response times than vancomycin in patients with methicillin-sensitive Staphylococcus aureus (MSSA) bloodstream infections, suggesting a potential shift in first-line treatment choices.

HER2-Targeted Therapy Extends Gastric Cancer Survival: ASCO 2025

Second-line treatment with trastuzumab deruxtecan has been shown to extend overall survival by more than 3 months in patients with advanced HER2-positive gastric or gastroesophageal junction adenocarcinoma (GEJA) following progression on first-line therapy, according to Phase III data from the DESTINY-Gastric04 trial presented at the ASCO 2025 Annual Meeting.